CG Oncology (CGON) Other Non-Current Liabilities (2023 - 2026)

CG Oncology has reported Other Non-Current Liabilities for 3 years, with the latest figure at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (changed N/A YoY), and the FY2025 full-year result was $1.7 million, changed N/A from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $1.5 million, down from $1.7 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $3.8 million in Q3 2025, with the low at $365000.0 in Q4 2023.
• Historically, Other Non-Current Liabilities has averaged $1.8 million across 3 years, with a median of $1.6 million in 2025.